Suppr
超能文献

Untuning the tumor metabolic machine: Targeting cancer metabolism: a bedside lesson.

作者信息

Birsoy Kıvanç, Sabatini David M, Possemato Richard

机构信息

Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA, the Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

出版信息

Nat Med. 2012 Jul 6;18(7):1022-3. doi: 10.1038/nm.2870.

DOI:10.1038/nm.2870

PMID:22772555

Abstract

摘要

相似文献

Untuning the tumor metabolic machine: Targeting cancer metabolism: a bedside lesson.

Nat Med. 2012 Jul 6;18(7):1022-3. doi: 10.1038/nm.2870.

Cracking open window of opportunity trials.

J Clin Oncol. 2012 Jul 20;30(21):2573-5. doi: 10.1200/JCO.2012.42.3293. Epub 2012 May 7.

Doctors seek to prevent breast cancer recurrence by lowering insulin levels.

J Natl Cancer Inst. 2008 Apr 16;100(8):530-2. doi: 10.1093/jnci/djn119. Epub 2008 Apr 8.

Metformin: a diabetes drug for cancer, or a cancer drug for diabetics?

J Clin Oncol. 2012 Jul 20;30(21):2698-700. doi: 10.1200/JCO.2012.42.1677. Epub 2012 May 7.

Targeting cancer and immune cell metabolism with the complex I inhibitors metformin and IACS-010759.

Mol Oncol. 2024 Jul;18(7):1719-1738. doi: 10.1002/1878-0261.13583. Epub 2024 Jan 12.

Targeting AMPK in the treatment of malignancies.

J Cell Biochem. 2012 Feb;113(2):404-9. doi: 10.1002/jcb.23369.

The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathy.

Ann Oncol. 2009 Mar;20(3):592-5. doi: 10.1093/annonc/mdn758. Epub 2009 Jan 19.

Metformin-clinical pharmacology in PCOs.

J Med Life. 2015 Apr-Jun;8(2):187-92.

Molecular targets of metformin antitumor action.

Pharmacol Rep. 2016 Oct;68(5):918-25. doi: 10.1016/j.pharep.2016.04.021. Epub 2016 May 9.

Metformin in cancer therapy: a new perspective for an old antidiabetic drug?

Mol Cancer Ther. 2010 May;9(5):1092-9. doi: 10.1158/1535-7163.MCT-09-1186. Epub 2010 May 4.

引用本文的文献

Antitumor Effects of Metformin in Squamous Cell Carcinoma under Leptin Treatment Conditions.

Prev Nutr Food Sci. 2025 Aug 31;30(4):312-322. doi: 10.3746/pnf.2025.30.4.312.

Modulation of almonertinib resistance in non-small cell lung cancer by cancer-associated fibroblasts through HK2-mediated glycolysis and SKP2 signaling.

Discov Oncol. 2025 Feb 15;16(1):187. doi: 10.1007/s12672-025-01974-w.

Multi-omics characterization of esophageal squamous cell carcinoma identifies molecular subtypes and therapeutic targets.

JCI Insight. 2024 Apr 23;9(10):e171916. doi: 10.1172/jci.insight.171916.

Novel Re(I) Complexes as Potential Selective Theranostic Agents in Cancer Cells and in Tumoral Strains.

J Med Chem. 2024 May 23;67(10):7891-7910. doi: 10.1021/acs.jmedchem.3c01869. Epub 2024 Mar 7.

Metabolism of Proliferating Cells.

Cold Spring Harb Perspect Biol. 2021 Oct 1;13(10):a040618. doi: 10.1101/cshperspect.a040618.

Spontaneously Resolving Joint Inflammation Is Characterised by Metabolic Agility of Fibroblast-Like Synoviocytes.

Front Immunol. 2021 Aug 26;12:725641. doi: 10.3389/fimmu.2021.725641. eCollection 2021.

MicroRNA-195 controls MICU1 expression and tumor growth in ovarian cancer.

EMBO Rep. 2020 Oct 5;21(10):e48483. doi: 10.15252/embr.201948483. Epub 2020 Aug 27.

Mitochondrial Metabolism as a Target for Cancer Therapy.

Cell Metab. 2020 Sep 1;32(3):341-352. doi: 10.1016/j.cmet.2020.06.019. Epub 2020 Jul 14.

New drugs are not enough‑drug repositioning in oncology: An update.

Int J Oncol. 2020 Mar;56(3):651-684. doi: 10.3892/ijo.2020.4966. Epub 2020 Jan 20.

c-Myc-Induced Long Non-Coding RNA Small Nucleolar RNA Host Gene 7 Regulates Glycolysis in Breast Cancer.

J Breast Cancer. 2019 Dec;22(4):533-547. doi: 10.4048/jbc.2019.22.e54.

本文引用的文献

Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo.

Cell Metab. 2012 Jun 6;15(6):827-37. doi: 10.1016/j.cmet.2012.05.001.

Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation.

Science. 2012 May 25;336(6084):1040-4. doi: 10.1126/science.1218595.

Metformin use is associated with better survival of diabetic patients with pancreatic cancer.

Clin Cancer Res. 2012 May 15;18(10):2905-12. doi: 10.1158/1078-0432.CCR-11-2994. Epub 2012 Mar 31.

Metabolic reprogramming: a cancer hallmark even warburg did not anticipate.

Cancer Cell. 2012 Mar 20;21(3):297-308. doi: 10.1016/j.ccr.2012.02.014.

Increased FDG uptake in breast cancer is associated with prognostic factors.

Ann Nucl Med. 2012 May;26(4):345-50. doi: 10.1007/s12149-012-0579-2. Epub 2012 Feb 24.

Functional genomics reveal that the serine synthesis pathway is essential in breast cancer.

Nature. 2011 Aug 18;476(7360):346-50. doi: 10.1038/nature10350.

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

Cancer Prev Res (Phila). 2010 Nov;3(11):1451-61. doi: 10.1158/1940-6207.CAPR-10-0157. Epub 2010 Oct 12.

IDH mutations in glioma and acute myeloid leukemia.

Trends Mol Med. 2010 Sep;16(9):387-97. doi: 10.1016/j.molmed.2010.07.002. Epub 2010 Aug 5.

Targeting energy metabolism in brain cancer through calorie restriction and the ketogenic diet.

J Cancer Res Ther. 2009 Sep;5 Suppl 1:S7-15. doi: 10.4103/0973-1482.55134.

Tumours with PI3K activation are resistant to dietary restriction.

Nature. 2009 Apr 9;458(7239):725-31. doi: 10.1038/nature07782. Epub 2009 Mar 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Untuning the tumor metabolic machine: Targeting cancer metabolism: a bedside lesson.

Nat Med. 2012 Jul 6;18(7):1022-3. doi: 10.1038/nm.2870.

Cracking open window of opportunity trials.

J Clin Oncol. 2012 Jul 20;30(21):2573-5. doi: 10.1200/JCO.2012.42.3293. Epub 2012 May 7.

Doctors seek to prevent breast cancer recurrence by lowering insulin levels.

J Natl Cancer Inst. 2008 Apr 16;100(8):530-2. doi: 10.1093/jnci/djn119. Epub 2008 Apr 8.

Metformin: a diabetes drug for cancer, or a cancer drug for diabetics?

J Clin Oncol. 2012 Jul 20;30(21):2698-700. doi: 10.1200/JCO.2012.42.1677. Epub 2012 May 7.

Targeting cancer and immune cell metabolism with the complex I inhibitors metformin and IACS-010759.

Mol Oncol. 2024 Jul;18(7):1719-1738. doi: 10.1002/1878-0261.13583. Epub 2024 Jan 12.

Targeting AMPK in the treatment of malignancies.

J Cell Biochem. 2012 Feb;113(2):404-9. doi: 10.1002/jcb.23369.

The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathy.

Ann Oncol. 2009 Mar;20(3):592-5. doi: 10.1093/annonc/mdn758. Epub 2009 Jan 19.

Metformin-clinical pharmacology in PCOs.

J Med Life. 2015 Apr-Jun;8(2):187-92.

Molecular targets of metformin antitumor action.

Pharmacol Rep. 2016 Oct;68(5):918-25. doi: 10.1016/j.pharep.2016.04.021. Epub 2016 May 9.

Metformin in cancer therapy: a new perspective for an old antidiabetic drug?

Mol Cancer Ther. 2010 May;9(5):1092-9. doi: 10.1158/1535-7163.MCT-09-1186. Epub 2010 May 4.

引用本文的文献

Antitumor Effects of Metformin in Squamous Cell Carcinoma under Leptin Treatment Conditions.

Prev Nutr Food Sci. 2025 Aug 31;30(4):312-322. doi: 10.3746/pnf.2025.30.4.312.

Modulation of almonertinib resistance in non-small cell lung cancer by cancer-associated fibroblasts through HK2-mediated glycolysis and SKP2 signaling.

Discov Oncol. 2025 Feb 15;16(1):187. doi: 10.1007/s12672-025-01974-w.

Multi-omics characterization of esophageal squamous cell carcinoma identifies molecular subtypes and therapeutic targets.

JCI Insight. 2024 Apr 23;9(10):e171916. doi: 10.1172/jci.insight.171916.

Novel Re(I) Complexes as Potential Selective Theranostic Agents in Cancer Cells and in Tumoral Strains.

J Med Chem. 2024 May 23;67(10):7891-7910. doi: 10.1021/acs.jmedchem.3c01869. Epub 2024 Mar 7.

Metabolism of Proliferating Cells.

Cold Spring Harb Perspect Biol. 2021 Oct 1;13(10):a040618. doi: 10.1101/cshperspect.a040618.

Spontaneously Resolving Joint Inflammation Is Characterised by Metabolic Agility of Fibroblast-Like Synoviocytes.

Front Immunol. 2021 Aug 26;12:725641. doi: 10.3389/fimmu.2021.725641. eCollection 2021.

MicroRNA-195 controls MICU1 expression and tumor growth in ovarian cancer.

EMBO Rep. 2020 Oct 5;21(10):e48483. doi: 10.15252/embr.201948483. Epub 2020 Aug 27.

Mitochondrial Metabolism as a Target for Cancer Therapy.

Cell Metab. 2020 Sep 1;32(3):341-352. doi: 10.1016/j.cmet.2020.06.019. Epub 2020 Jul 14.

New drugs are not enough‑drug repositioning in oncology: An update.

Int J Oncol. 2020 Mar;56(3):651-684. doi: 10.3892/ijo.2020.4966. Epub 2020 Jan 20.

c-Myc-Induced Long Non-Coding RNA Small Nucleolar RNA Host Gene 7 Regulates Glycolysis in Breast Cancer.

J Breast Cancer. 2019 Dec;22(4):533-547. doi: 10.4048/jbc.2019.22.e54.

本文引用的文献

Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo.

Cell Metab. 2012 Jun 6;15(6):827-37. doi: 10.1016/j.cmet.2012.05.001.

Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation.

Science. 2012 May 25;336(6084):1040-4. doi: 10.1126/science.1218595.

Metformin use is associated with better survival of diabetic patients with pancreatic cancer.

Clin Cancer Res. 2012 May 15;18(10):2905-12. doi: 10.1158/1078-0432.CCR-11-2994. Epub 2012 Mar 31.

Metabolic reprogramming: a cancer hallmark even warburg did not anticipate.

Cancer Cell. 2012 Mar 20;21(3):297-308. doi: 10.1016/j.ccr.2012.02.014.

Increased FDG uptake in breast cancer is associated with prognostic factors.

Ann Nucl Med. 2012 May;26(4):345-50. doi: 10.1007/s12149-012-0579-2. Epub 2012 Feb 24.

Functional genomics reveal that the serine synthesis pathway is essential in breast cancer.

Nature. 2011 Aug 18;476(7360):346-50. doi: 10.1038/nature10350.

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

Cancer Prev Res (Phila). 2010 Nov;3(11):1451-61. doi: 10.1158/1940-6207.CAPR-10-0157. Epub 2010 Oct 12.

IDH mutations in glioma and acute myeloid leukemia.

Trends Mol Med. 2010 Sep;16(9):387-97. doi: 10.1016/j.molmed.2010.07.002. Epub 2010 Aug 5.

Targeting energy metabolism in brain cancer through calorie restriction and the ketogenic diet.

J Cancer Res Ther. 2009 Sep;5 Suppl 1:S7-15. doi: 10.4103/0973-1482.55134.

Tumours with PI3K activation are resistant to dietary restriction.

Nature. 2009 Apr 9;458(7239):725-31. doi: 10.1038/nature07782. Epub 2009 Mar 11.

Suppr超能文献

Untuning the tumor metabolic machine: Targeting cancer metabolism: a bedside lesson.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译